<code id='5C47F66714'></code><style id='5C47F66714'></style>
    • <acronym id='5C47F66714'></acronym>
      <center id='5C47F66714'><center id='5C47F66714'><tfoot id='5C47F66714'></tfoot></center><abbr id='5C47F66714'><dir id='5C47F66714'><tfoot id='5C47F66714'></tfoot><noframes id='5C47F66714'>

    • <optgroup id='5C47F66714'><strike id='5C47F66714'><sup id='5C47F66714'></sup></strike><code id='5C47F66714'></code></optgroup>
        1. <b id='5C47F66714'><label id='5C47F66714'><select id='5C47F66714'><dt id='5C47F66714'><span id='5C47F66714'></span></dt></select></label></b><u id='5C47F66714'></u>
          <i id='5C47F66714'><strike id='5C47F66714'><tt id='5C47F66714'><pre id='5C47F66714'></pre></tt></strike></i>

          Home / comprehensive / entertainment

          entertainment


          entertainment

          author:leisure time    Page View:3227
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In